Efficacy and Safety Evaluation of BZ371B in ARDS Patients

Summary

The purpose of this study is to evaluate safety, tolerability and efficacy of BZ371B in intubated patients with severe Acute Respiratory Distress Syndrome.

Timeline

Start

2022-11-23

Primary completion

2023-03-03

Completion

2023-03-03

Outcome

Outcome not reported

Stopped (Enrollment): “Suboptimal enrollment”

Drugs

Indications